These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14581533)

  • 1. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector.
    Lee MT; Coburn GA; McClure MO; Cullen BR
    J Virol; 2003 Nov; 77(22):11964-72. PubMed ID: 14581533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages.
    Song E; Lee SK; Dykxhoorn DM; Novina C; Zhang D; Crawford K; Cerny J; Sharp PA; Lieberman J; Manjunath N; Shankar P
    J Virol; 2003 Jul; 77(13):7174-81. PubMed ID: 12805416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
    Cordelier P; Morse B; Strayer DS
    Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.
    Qin XF; An DS; Chen IS; Baltimore D
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):183-8. PubMed ID: 12518064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
    Morris KV; Rossi JJ
    Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.
    Amara A; Vidy A; Boulla G; Mollier K; Garcia-Perez J; Alcamí J; Blanpain C; Parmentier M; Virelizier JL; Charneau P; Arenzana-Seisdedos F
    J Virol; 2003 Feb; 77(4):2550-8. PubMed ID: 12551993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
    Coburn GA; Cullen BR
    J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.
    Muratori C; Schiavoni I; Melucci-Vigo G; Olivetta E; Santarcangelo AC; Pugliese K; Verani P; Federico M
    Hum Gene Ther; 2002 Sep; 13(14):1751-66. PubMed ID: 12396627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.
    Anderson J; Li MJ; Palmer B; Remling L; Li S; Yam P; Yee JK; Rossi J; Zaia J; Akkina R
    Mol Ther; 2007 Jun; 15(6):1182-8. PubMed ID: 17406343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.
    Nishitsuji H; Ikeda T; Miyoshi H; Ohashi T; Kannagi M; Masuda T
    Microbes Infect; 2004 Jan; 6(1):76-85. PubMed ID: 14738896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
    Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
    Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.
    Zhou J; Satheesan S; Li H; Weinberg MS; Morris KV; Burnett JC; Rossi JJ
    Chem Biol; 2015 Mar; 22(3):379-90. PubMed ID: 25754473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
    Morris KV; Rossi JJ
    Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.